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Abstract 
Background: Nodding syndrome (NS) is an epilepsy disorder occurring in children in South Sudan, northern Uganda 
and Tanzania. The etiology of NS is unknown, but epidemiological studies demonstrate an association between NS 
and onchocerciasis.
Methods: Between November 2013 and July 2015 we visited onchocerciasis endemic regions in South Sudan, 
Uganda, and the Democratic Republic of the Congo (DRC) to assess the epilepsy situation. In South Sudan we 
interviewed patients and affected families, health officials, colleagues and healthcare workers, and performed a small 
household survey to estimate the epilepsy prevalence in the village of Mvolo, Western Equatoria State. Most informa-
tion from Uganda was collected through discussions with colleagues and a review of published literature and reports. 
In the Bas-Uélé district of the DRC, we visited the villages of Liguga, Titule and Dingila, interviewed patients with 
epilepsy and family members and conducted a preliminary entomological assessment.
Results: In South Sudan there is an ongoing NS and epilepsy epidemic in the Western Equatoria state that started 
around 1990. A survey of 22 households in Mvolo revealed that 28 out of 168 (16.7 %) children suffered from NS or 
another form of epilepsy. Thirteen (59 %) households had at least one child, and nine (41 %) households at least two 
children with NS or another form of epilepsy. In northern Uganda, an NS and epilepsy epidemic started around 2000. 
The occurrence of new NS cases has been in decline since 2008 and no new NS cases were officially reported in 
2013. The decline in NS cases coincided with the bi-annual distribution of ivermectin and the treatment of blackfly-
breeding rivers with larvicides. In Bas-Uélé district in the DRC, epilepsy appears to be endemic with cases clustered 
in villages close to blackfly-infested, rapid-flowing rivers. The majority of epilepsy cases in Liguga, Dingila and Titule 
presented with generalized (tonic–clonic) seizures without nodding, but with mental retardation. In Titule, an epilepsy 
prevalence of 2.3 % was documented. The only anthropophilic species of blackfly collected in the region belonged to 
the Simulium damnosum complex.
Conclusion: Blackflies may play a key role in the transmission of an etiological agent that either directly or indirectly 
cause, not only NS, but also other forms of epilepsy in onchocerciasis endemic regions.
© 2016 Colebunders et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International 
License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any 
medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons 
license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.
org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Open Access
BMC Research Notes
*Correspondence:  robert.colebunders@uantwerpen.be 
1 Global Health Institute, Gouverneur Kinsbergen Centrum, University 
of Antwerp, Doornstraat 331, 2610 Antwerp, Belgium
Full list of author information is available at the end of the article
Page 2 of 9Colebunders et al. BMC Res Notes  (2016) 9:182 
Background
Nodding syndrome (NS) is an epilepsy disorder occur-
ring in children in onchocerciasis endemic regions of 
South Sudan, Uganda and Tanzania [1]. NS is character-
ized by episodes of head nodding, a form of atonic epi-
leptic seizure [2]. As the condition progresses individuals 
may develop other types of seizure and experience devel-
opmental retardation and growth stunting [1]. The head 
nodding seizures are often cited as being triggered by eat-
ing local foods [1, 3]. NS has severe socioeconomic impli-
cations and like other forms of epilepsy, it is associated 
with social stigma. Many children have died as a result of 
uncontrolled seizures that have led to drowning or burn-
ing [1]. The pathogenesis of NS is currently unknown, 
and although various infectious, toxic, nutritional, psy-
chosocial and genetic causes have been proposed and 
investigated, none have been confirmed [1, 4, 5]. How-
ever, it is known that NS only occurs in onchocerciasis 
endemic regions and epidemiological studies indicate 
an association between NS and onchocerciasis [1, 6]. A 
meta-analysis of African data supports the hypothesis 
that a high intensity of Onchocerca volvulus infection is 
associated with epilepsy [7, 8].
This paper considers the current status of NS and epi-
lepsy in three onchocerciasis endemic regions of South 
Sudan, Uganda, and the Democratic Republic of the 
Congo (DRC). It highlights gaps in current knowledge 
and proposes new approaches to studying the epidemiol-
ogy of this neglected tropical condition.
Methods
Between November 2013 and July 2015, we visited three 
onchocerciasis endemic regions, one in South-Sudan 
(Western Equatoria State), one in northern Uganda 
(Gulu, Kitgum, Pader and Lamwo districts), and one in 
the DRC (Orientale Province), to assess the NS and epi-
lepsy situation. We used the 2012 World Health Organi-
zation (WHO) suspected case definition of NS [9] and a 
history of unprovoked seizures as a definition for epilepsy 
[10].
In South Sudan, we visited the towns and villages of 
Mundri, Yeri and Mvolo (N6.060121, E29.952274), and 
Lui Hospital between 19th and 26th November 2013. In 
each location we interviewed patients and affected fami-
lies, health officials and healthcare workers. In Mvolo 
(N6.060121, E29.952274), we performed a small house-
hold survey to estimate the prevalence of epilepsy in the 
village. The survey was carried out over 2 days by a team 
consisting of R. Colebunders, M. van Oyen (neurologist), 
S. Komoyngi (chairman of a local NGO to support 
patients with nodding syndrome) and J. Podi (community 
health worker in Mvolo).
The northern Ugandan towns and trading centers of 
Gulu, Kitgum, and Padwat Central were visited on 27th 
November 2013. On 26th July 2015 we visited the NS 
treatment facility “Hope for Humans” in Odek, and on 
30th July, Tumangu, a village in Kitgum district where 
105 NS cases were recorded during a 2012 Ministry of 
Health survey. Most information about Uganda was 
collected through discussions with colleagues and in a 
review of published literature and reports.
In March 2014, an initial exploratory mission to the 
Bas Uélé district of the DRC included visits to Dingila 
(N3.68336, E26.03611), Titule (N3.28150, E25.52894) 
and Liguga (N3.40253, E25.02586). This was followed 
by a second mission to Dingila and Titule between 8th 
and 19th June 2014. Dingila is located along the Uélé 
river and Titule is located along the Bima river which is a 
major tributary of the Uélé. Liguga is situated at the con-
fluence of the two rivers. The main socio-economic activ-
ities in the region are agriculture and fishing. In all three 
towns we interviewed patients with epilepsy and family 
members. In Titule, a preliminary entomological assess-
ment was also conducted to identify the predominant 
human-biting blackfly species.
Human subjects
Approval of study protocols was obtained from the 
Sudanese Ministry of Health ethics committee, from the 
Ministry of Health of the Orientale Province, and the 
ethics committee of the University of Kisangani, DRC. 
Informed consent was obtained from patients and fami-
lies who were interviewed. In Uganda we did not perform 
any interviews with patients and families, information 
was obtained through discussions with colleagues and a 
review of published literature and reports.
Entomological studies
Authorization to collect, transport and ship biologi-
cal material was granted by the Biodiversity Monitoring 
Center (CSB, Centre de Surveillance de la Biodiversité), 
at the University of Kisangani, DRC.
Results
South Sudan
In the villages of Mundri, Yeri and Mvolo, and in Lui 
Hospital, local authorities and healthcare workers con-
sidered epilepsy to be one of the major public health 
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problems in the region. Families reported the first cases 
of NS around 1990. Mvolo, a village located 700 m from 
the large and fast-flowing Naam River, was reported to be 
one of the most severely affected villages. We decided to 
stay for 2 days to investigate the epilepsy situation. Mvolo 
is infested with blackflies of the S. damnosum species 
complex [11]. The Naam River is a focal point for com-
munities, where men fish, children swim, women wash 
clothes, and cows graze along the riverbanks. The river 
becomes very crowded during the fishing season.
The burden of epilepsy was obvious when visiting 
households in the village. Many children had signs of 
burns or other injuries resulting from epileptic seizures. 
A survey of 22 households randomly chosen in two dif-
ferent parts of Mvolo revealed that epilepsy affected 
28 out of 168 (16.7  %) children. Thirteen (59  %) house-
holds had at least one child with NS or another form of 
epilepsy, and nine (41 %) had at least two children with 
NS or another form of epilepsy. Different types of epi-
lepsy (NS, and also convulsive epilepsy not meeting the 
WHO NS case definition) were often reported in the 
same family. Generalized epileptic seizures and cogni-
tive deterioration were reported in most children, and 
several presented with stunted growth and lack of sec-
ondary sexual characteristics. The overall epilepsy preva-
lence was estimated to be 9.2 % (28/306) in Mvolo, and 
this observation is similar to a prevalence estimate for 
Mvolo County of 8.4 % (4025/48,100), made by the South 
Sudan Relief and Rehabilitation Commission (A. Amba, 
personal communication). These prevalence figures are 
twice as high as the February 2001 WHO estimates of 
4.6 % [3]. There was a common belief among many villag-
ers that epilepsy is transmitted from one child to another. 
Children with epilepsy were often separated from other 
children and some were even abandoned. During the 
1-week visit to the affected area, villagers reported that 
two young girls had drowned as the result of seizures 
while washing clothes in the river.
The distribution of annual doses of ivermectin to resi-
dents of Mvolo started in 1996, but the treatment was 
interrupted several times during periods of conflict (S. 
Komyangi, personal communication). Recent ivermectin 
coverage is very low and many new cases of epilepsy con-
tinued to appear in Mvolo (J. Podi, May 2015 personal 
communication). Moreover, high rates of seizures and 
head nodding were also reported from another oncho-
cerciasis endemic region of South Sudan, in Raga County, 
Western Bahr El Ghazal. (Y. Biajo, August 2015 personal 
communication). In South Sudan, very few patients with 
epilepsy currently have access to anti-epileptic treatment.
Parts of South Sudan have been hyperendemic for 
human onchocerciasis since at least 1930, and local mis-
sionaries reported many combined cases of blindness 
and epilepsy in the 1950s [11]. Other Onchocerca spp. (O. 
armillata, O. fasciata and O. gutturosa) have also been 
reported in domestic animals from the same area [12, 13]. 
These filarial species can potentially be found in human-
biting blackflies (S. adersi, S. griseicolle and S. bovis) [13].
Uganda
The epidemic of NS and epilepsy in northern Uganda 
started during the war between the Ugandan People’s 
Defence Force (UPDF) and the Lord’s Resistance Army 
(LRA). The earliest reported onset of NS was in 1997, 
with the majority of cases occurring beyond 2000, dur-
ing which time up to 90  % of the war-affected popula-
tion were forced into internally displaced persons’ (IDP) 
camps [6]. Many IDP camps were situated close to the 
fast-flowing Achwa and Pager rivers which were infested 
with blackflies. Ivermectin was not distributed during the 
conflict and the extent of onchocerciasis was not known 
[14, 15]. This probably resulted in high O. volvulus infec-
tion rates in children with weakened immune systems 
caused by malnutrition and co-infections. Mass drug 
administration (MDA) with ivermectin only commenced 
in Kitgum and Pader districts in 2008. Both Kitgum and 
Pader were severely affected by NS. Meanwhile, in nearby 
Adjumani district which has been under MDA for over 
15 years, no NS cases have been reported.
The reported clinical manifestations associated with 
NS in South Sudan and northern Uganda were found to 
be very similar. In Uganda, management guidelines for 
the treatment and care of patients with NS were devel-
oped in 2012 [16, 17]. Treatment centers are present in 
all affected districts and are staffed by multi-disciplinary 
teams of healthcare workers. They provided not only 
anti-epileptic treatment, but also support for behavioral 
and emotional difficulties, nutritional therapy, and physi-
cal and cognitive rehabilitation. Sodium valproate is the 
first-line anticonvulsant administered to NS/epilepsy 
patients [17]. Treatment center teams are supported by 
village-based lay health volunteers who provide ambula-
tory care in homes of patients with NS [17]. An evalua-
tion of this program showed that substantial clinical and 
functional improvements can be obtained with symp-
tomatic treatment, suggesting that NS is not a progres-
sive, debilitating disease, and could even be a reversible 
encephalopathy in some patients [17].
Whereas the NS epidemic is still ongoing in South 
Sudan, it appears to have abated in northern Uganda [18, 
19]. Uganda is one of three countries in Africa that com-
bine MDA of ivermectin with vector control in order to 
control onchocerciasis (the other countries being Tanza-
nia and Equatorial Guinea) [20]. MDA of ivermectin was 
introduced to NS-affected districts of northern Uganda 
in 2008, and distribution has been biannual since March 
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2012. Ivermectin MDA was supported by vector control 
interventions, which began with the aerial application 
of insecticides to S. damnosum breeding-sites along the 
Achwa and Pager rivers in late-2012. Aerial spraying has 
since been followed by regular application of larvicides 
(temephos) to rivers during rainy seasons. Incidence 
of NS cases has declined in Pader district since 2008, in 
Lamwo since 2010, and in Kitgum since 2011, with no 
new NS cases officially reported in Uganda in 2013 [18].
Simulium damnosum s.str. is the likely vector of O. vol-
vulus in northern Uganda [21], although a recent (unpub-
lished) survey of biting flies indicates that a member of 
the Simulium bovis group accounts for approximately 
half of the human-biting flies within the NS-affected dis-
tricts of Kitgum and Lamwo [4].
Democratic Republic of the Congo
In Liguga, 31 randomly chosen families were interviewed. 
The population of Liguga health area is 5643, while the 
town has an estimated 744 inhabitants (Census Com-
munity distributor, 2013). Of the 161 children (<18 years 
old) in the 31 families, five (3.1 %) suffered from epilepsy. 
Fifty percent of the families reported that at least on child 
in the family died; 7.9 % of the deaths were caused by epi-
lepsy (epilepsy attack or by drowning).
The majority of epilepsy cases in Liguga, Dingila and 
Titule presented with generalized (tonic–clonic) seizures 
without nodding, but with mental retardation. In Titule, 
in a house to house survey, the prevalence of epilepsy was 
2.3 % and patients with epilepsy were clustered in fami-
lies generally living very close to the rapid-flowing Bima 
River, which is infested with blackflies [22]. In the three 
towns, no patients meeting the strict WHO NS case defi-
nition were observed, but some children with epilepsy 
presented with stunted growth and lack of secondary sex-
ual characteristics. A case control study was performed 
in Titule, details of which will be reported elsewhere. 
Food was not reported to be a major triggering factor of 
seizures in Titule, in contrast to what has been reported 
in South Sudan and northern Uganda [1]. Twenty-seven 
patients with epilepsy were monitored following con-
sumption of local foods, but none developed head nod-
ding or epileptic seizures. Most children with epilepsy 
had dropped out of primary school very early because of 
learning difficulties and stigma associated with epilepsy.
Phenobarbital was available in pharmacies of the vil-
lages visited. However, in Titule, 33 (58 %) of 57 patients 
with generalized convulsive epilepsy had never taken any 
anti-epileptic medication. In Titule, ivermectin has been 
distributed annually since 2002. The coverage during the 
first year of ivermectin distribution was reported to be 
23  % (F. Tepage, personal communication). From June 
2004 to 2005 ivermectin distribution was temporarily 
stopped because of reported deaths associated with 
ivermectin use in Loa Loa co-infected patients in the 
Bas-Congo [23]. Later MDA of ivermectin was restarted 
and the coverage increased over the years in Titule to 
73–81  %. However, of 142 patients with epilepsy inter-
viewed in Titule, 105 (73.9 %) had not taken ivermectin 
prior to the onset of epilepsy.
In Dingila, a family comprising a husband, two wives 
and 22 children was interviewed. The husband had seven 
children with his first wife, four of whom were aged 9, 
12, 18 and 20 years and had epilepsy. He had 15 children 
with his second wife, two of whom were aged 14 and 
15 years and had epilepsy. The father used to be a fisher-
man who had lived for many years in Gbango (N3.71321, 
E26.00938), a small settlement on the bank of the Uélé 
River. All his children with epilepsy had lived in Gbango 
since birth. The fisherman decided to abandon the set-
tlement and moved 12  km away to Dingila because he 
believed the epilepsy in his children was somehow asso-
ciated with the river and witchcraft. None of the 15 chil-
dren born and raised in Dingila have so far developed 
epilepsy.
Simulium damnosum complex blackflies were the 
dominant species breeding along the main rivers near 
both surveyed villages and are the principal vectors of 
O. volvulus. While infection rate of the specimens col-
lected during this study is yet to be determined, dissec-
tions of adult flies, caught in Titule in 1941, had revealed 
an infection rate of O. volvulus of 18  % [24]. Histori-
cal records also mention the presence of human-biting 
members of the S. neavei group in the same region. Simu-
lium albivirgulatum, which has potential to bite humans, 
is also present in the DRC including Bas-Uélé district 
[25]. Both S. neavei and S. albivirgulatum are capable 
of transmitting O. volvulus. However, during the survey 
in Titule and Dingila, the only anthropophilic species 
collected belonged to the S. damnosum complex. Three 
ornithophilic species were collected in tributaries of both 
the Bima and Bas-Uélé rivers, namely: S. cervicornutum, 
S. unicornutum and S. schoutedeni (identified by R. Post, 
personal communication). Table  1 summarizes the cur-
rent status of epilepsy in the three countries of interest.
Discussion
Observations in South Sudan suggest that there is an 
ongoing NS and epilepsy epidemic in the Western 
Equatoria state, while in northern Uganda the epidemic 
appears to have abated. No new NS cases were officially 
reported in Uganda in 2013 [18], and only two new NS 
cases have been reported since then (B. Opar, July 2015 
personal communication).
However, our findings should be interpreted with cau-
tion. Indeed, during our short site visits, we were unable 
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to perform in-depth and well-designed epidemiological 
investigations. However, based on our rapid assessment 
of the epilepsy situation in the three countries, it is clear 
that there is an urgent need to better quantify and moni-
tor the burden of epilepsy in onchocerciasis endemic 
regions.
Nodding syndrome and epilepsy epidemics in both 
South Sudan and northern Uganda occurred in regions 
hyperendemic for onchocerciasis. In each country, the 
epidemic occurred at a time where the population lacked 
access to ivermectin treatment due to disruption in 
infrastructure caused by civil conflicts [26]. Population 
displacement, and the location of internally displaced 
person (IDP) camps close to blackfly infested rivers, 
where the population had limited access to water from 
boreholes, may have contributed to these epidemics. 
Moreover, the lack of epilepsy treatment during the war 
and in the post-war period may explain the severe forms 
of cognitive impairment observed in children with NS in 
both countries.
Whether the distribution of ivermectin and/or blackfly 
control interventions resulted in a decrease in NS cases 
in northern Uganda remains to be proven. The use of a 
stricter NS case-definition in recent years [27] cannot 
explain the dramatic decrease of NS cases post 2013. 
However, the already decreasing incidence of NS cases 
prior to the bi-annual distribution of ivermectin and lar-
viciding of rivers in 2012 could be a result of the annual 
ivermectin treatment regimen already in place.
In the Bas-Uélé district of DRC, epilepsy also appears 
to be an important public health problem. Prevalence 
studies in other districts of the Orientale Province are 
now also being conducted by the University of Kisangani 
in collaboration with the Ministry of Health in order to 
determine the magnitude of the problem. Preliminary 
data show a prevalence of epilepsy between 2 and 6 % in 
many villages in the province located near rapid flowing 
rivers (A. Laudisoit unpublished results). Not all epilepsy 
in the region will be associated with onchocerciasis, and 
cysticercosis needs to be excluded as a possible cause, 
especially given the high number of pigs kept domesti-
cally. In Dingila, however, Dr. J.L. Lumaliza collected 
blood on filter paper from 40 individuals with epilepsy, 
yet none revealed the presence of cysticercosis antibodies 
when analysed by enzyme-linked immunoelectrotransfer 
blot (S. Gabriel unpublished results).
Cases meeting the WHO-approved definition of NS 
were not observed in Liguga, Dingila, and Titule, but NS-
like manifestations were observed (epilepsy cases with 
stunted growth and lack of secondary sexual character-
istics). Suspected cases of NS have also previously been 
seen by one of us (M. Mandro, unpublished report) in the 
Logo health zone in Ituri, Orientale Province, DRC.
NS seems to be one of many different types of epi-
lepsy present in onchocerciasis endemic regions. In 
these regions, different types of epilepsy, including NS 
and convulsive epilepsy that do not meet the WHO case 
definition of NS occur among children within the same 
family, suggesting that different clinical presentations of 
epilepsy may be caused by a common trigger the family 
is exposed to.
By strictly adhering to the WHO case definition of NS, 
we may significantly underestimate the burden of the dis-
ease. A recent study to estimate the prevalence of NS in 
three districts of northern Uganda highlighted the diffi-
culty in applying the WHO NS case definition [27].
Epidemic epilepsy of unknown etiology, clustered in 
onchocerciasis areas, has previously been referred to as 
“river epilepsy” by French researchers working in the 
Mbam valley, an onchocerciasis endemic area in Came-
roon [8, 28]. A similar type of epilepsy seems to be present 
in the DRC. The presence in the DRC of epilepsy with an 
onset of during childhood in older people suggests that it is 
not necessarily a progressive degenerative disease and that 
it has been endemic in the Province Orientale of the DRC 
for a long time. Recent studies in Tanzania and Uganda 
also suggest that NS is not necessarily a progressive disease 
[16, 29, 30]. Most children with NS who receive adequate 
care, including anti-epileptic treatment, nutritional and 
emotional support, and physical rehabilitation, improve 
clinically. A reduced frequency of seizures and even rever-
sal of severe functional disabilities have been reported, 
including by the NS treatment center “Hope for Humans”, 
which we visited in Odek [16, 29]. There is an urgent need 
for the government of South Sudan to replicate the Ugan-
dan NS care and treatment program in their affected vil-
lages, to provide funding and seek relevant expertise in 
order to implement such a program.
Living in close proximity to rapid-flowing, blackfly-
infested rivers, and in areas of low ivermectin coverage, 
appear to be the common factors in the three regions 
of South Sudan, northern Uganda and DRC with a high 
prevalence of epilepsy. Blackflies may play a key role in 
transmitting an etiological agent that directly or indi-
rectly is causing epilepsy. Our preliminary observations 
support the need to conduct fundamental and systematic 
research on Onchocerca spp., their hosts, and vectors in 
these regions. For example, the possible occurrence of 
novel strains of Onchocerca and associated Wolbachia in 
areas of high epilepsy prevalence should be investigated. 
It is already suspected, but not confirmed, that different 
O. volvulus strains exist that are responsible for differ-
ences observed in clinical disease (blinding/skin lesions) 
[31].
A recent study suggests that an antibody-mediated 
autoimmune response to leiomodin-1 is involved in the 
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etiology of NS, and that autoimmunity due to molecu-
lar mimicry of an O. volvulus surface protein contrib-
utes to NS pathogenesis [32]. The authors showed that 
11 (58  %) of 19 patients with NS had detectable serum 
autoantibodies to leiomodin-1, compared to five (26 %) of 
19 controls (matched OR 7.0, 95  % CI 0.9–11.1). These 
antibodies, which are also present in the CSF of patients 
with NS, were found to be neurotoxic in vitro and cross-
reacted with O. volvulus tropomyosin which has regions 
of significant homology with leiomodin-1. While it is 
hard to envisage that the target of functional antibod-
ies against O. volvulus is a muscle isoform of tropomyo-
sin (which is only exposed when microfilariae are dead), 
it seems possible that the muscle isoform from dying or 
dead microfilariae induces a humoral response that gives 
rise to cross-reactivity with a non-muscle form, leading 
to active parasite destruction most likely through an anti-
body-dependent cell-mediated cytotoxicity reaction [33]. 
It has been suggested that the pathogenesis of retinocho-
roidal changes in onchocerciasis is also due to an autoim-
mune reaction involving cross-reacting antigens between 
O. volvulus and retinal components [34–38]. In a recent 
study in Uganda, serum antibodies against voltage gated 
potassium channel (VGKC)-complex proteins were 
detected in 15 (48  %) of 31 patients with NS compared 
to only in 1 (9 %) of 11 sibling controls (R. Idro, unpub-
lished). Such antibodies were previously not detected 
among patients with NS in Tanzania [5] but there have 
been concerns about the methodology that was used to 
detect these antibodies in the Tanzanian study.
If we can demonstrate that improving ivermectin cov-
erage can decrease the incidence of onchocerciasis asso-
ciated epilepsy or “river epilepsy”, this will improve the 
acceptance of the drug among populations where oncho-
cerciasis is largely asymptomatic, and it would be an 
additional argument to strengthen onchocerciasis elimi-
nation efforts.
The burden of disease caused by epilepsy in oncho-
cerciasis endemic areas is much higher than the 3300 
estimated cases of NS in Uganda [27]. Indeed, a high 
prevalence of epilepsy has been reported in many oncho-
cerciasis endemic areas [7, 8, 39–43]. The prevalence 
of epilepsy in three African demographic surveillance 
sites, non-endemic for onchocerciasis (Agincourt, South 
Africa; Iganga-Mayuge, Uganda; and Kilifi, Kenya), was 
2.3 per 1000 (ten times lower than the prevalence in Tit-
ule) [44].
NS and “onchocerciasis associated epilepsy” (or “river 
epilepsy”) remain very neglected public health problems. 
It was only in April 2014 that was NS added to the WHO 
list of neglected tropical diseases as “another condition”. 
In Table  2 we propose a clinical definition of “oncho-
cerciasis associated epilepsy” (or “river epilepsy”) that 
could be used for surveillance purposes. A multi-coun-
try, multidisciplinary research effort will be required to 
eliminate the suffering caused by this condition. We hope 
our preliminary data from South Sudan and the DRC 
not only will motivate funding agencies to support fur-
ther research on epilepsy in these remote onchocerciasis 
endemic regions, but above all will motivate them to fund 
and set up treatment programs for children with epilepsy 
in these regions.
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